These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1303414)

  • 1. Bio-availability and drug delivery systems: clinical perspective.
    Bhatt AD; Vaidya AB
    J Postgrad Med; 1992; 38(3):130-4. PubMed ID: 1303414
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
    Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
    Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industrial perspective in ocular drug delivery.
    Ali Y; Lehmussaari K
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
    Lee HJ; Amidon GL
    NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in absorption of BAY u 3405 along the human gastrointestinal tract.
    Fuhr U; Hoyer J; Ritter W; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):475-6. PubMed ID: 1490789
    [No Abstract]   [Full Text] [Related]  

  • 9. Colonic drug delivery: an updated review.
    Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
    AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from marketed and investigational prodrugs.
    Ettmayer P; Amidon GL; Clement B; Testa B
    J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379
    [No Abstract]   [Full Text] [Related]  

  • 11. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
    Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
    J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal fat absorption and its relevance in lipid drug delivery systems.
    Eldem T; Speiser P
    Pharmazie; 1989 Jul; 44(7):444-7. PubMed ID: 2682676
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?
    Youan BB
    J Control Release; 2004 Aug; 98(3):337-53. PubMed ID: 15312991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectins and glycoconjugates in drug delivery and targeting.
    Lehr CM; Gabor F
    Adv Drug Deliv Rev; 2004 Mar; 56(4):419-20. PubMed ID: 14969749
    [No Abstract]   [Full Text] [Related]  

  • 18. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
    Larsen T; Link A
    Angew Chem Int Ed Engl; 2005 Jul; 44(29):4432-4. PubMed ID: 15984039
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
    Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
    J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system.
    Civiale C; Ritschel WA; Shiu GK; Aiache JM; Beyssac E
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):491-8. PubMed ID: 1784147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.